Publications by authors named "Bendetta Puccini"
Article Synopsis
- About 19% of patients who relapsed after autologous hematopoietic stem cell transplantation (SCT) were treated with allogeneic SCT (allo-SCT) based on GITMO database analysis from 1995 to 2008.
- The overall response rate to allo-SCT was 49%, with 43% achieving a complete response, but 51% experienced rapid disease progression post-treatment.
- Factors impacting overall survival and progression-free survival were primarily the patient's status at the time of allo-SCT, illustrating the challenges in managing relapsed diffuse large B cell lymphoma.
